Biological Psychiatry最新文献

筛选
英文 中文
Expression of Concern to: "Gamma Secretase-Activating Protein Is a Substrate for Caspase-3: Implications for Alzheimer's Disease," by Chu et al. (Biol Psychiatry 2015; 77:720-728); https://doi.org/10.1016/j.biopsych.2014.06.003. 表达关注:“γ分泌酶激活蛋白是Caspase-3的底物:对阿尔茨海默病的影响”,由Chu等人(Biol Psychiatry 2015; 77:720-728);https://doi.org/10.1016/j.biopsych.2014.06.003。
IF 10.3 1区 医学
Biological Psychiatry Pub Date : 2026-10-16 DOI: 10.1016/j.biopsych.2026.10.007
{"title":"Expression of Concern to: \"Gamma Secretase-Activating Protein Is a Substrate for Caspase-3: Implications for Alzheimer's Disease,\" by Chu et al. (Biol Psychiatry 2015; 77:720-728); https://doi.org/10.1016/j.biopsych.2014.06.003.","authors":"","doi":"10.1016/j.biopsych.2026.10.007","DOIUrl":"10.1016/j.biopsych.2026.10.007","url":null,"abstract":"","PeriodicalId":8918,"journal":{"name":"Biological Psychiatry","volume":" ","pages":""},"PeriodicalIF":10.3,"publicationDate":"2026-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149206516","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neural Circuits of Social Behavior in Autism Spectrum Disorder: From Mechanism to Intervention. 自闭症谱系障碍社会行为的神经回路:从机制到干预。
IF 10.3 1区 医学
Biological Psychiatry Pub Date : 2026-10-13 DOI: 10.1016/j.biopsych.2026.10.006
Kally C O'Reilly Sparks, Ernest V Pedapati
{"title":"Neural Circuits of Social Behavior in Autism Spectrum Disorder: From Mechanism to Intervention.","authors":"Kally C O'Reilly Sparks, Ernest V Pedapati","doi":"10.1016/j.biopsych.2026.10.006","DOIUrl":"https://doi.org/10.1016/j.biopsych.2026.10.006","url":null,"abstract":"<p><strong>Introduction: </strong>Difficulties in social communication and interaction are core diagnostic features of autism spectrum disorder (ASD), yet interventions targeting these difficulties have modest and variable effects. Understanding mechanistically distinct contributions to social behaviors may identify new therapeutic opportunities.</p><p><strong>Methods: </strong>This narrative review integrates human neuroimaging studies, supporting rodent circuit neuroscience, clinical intervention research, and developmental studies. We organize the findings into four overlapping functional-computational domains and relate these domains to the Research Domain Criteria Social Processes framework.</p><p><strong>Results: </strong>The four domains are: (1) Social Reward and Social Interest, encompassing the incentive and hedonic value of social contact and motivation to engage; (2) Social Memory and Social-Affective Value, encompassing recognition of familiar individuals and learned affective or motivational associations; (3) Social Cue Perception, Action Representation, and Social Prediction/Timing, encompassing the processing and forecasting of dynamic social information; and (4) Higher-Order Social Cognition and Model Updating, encompassing mental-state inference and the updating of person-specific social models. Because these domains are not independent, interactions among reward, memory, cue processing, prediction, and higher-order inference create multiple possible developmental entry points, such that early differences in one process may alter experience-dependent learning in others. Evidence for specific causal cascades remains preliminary and requires longitudinal testing.</p><p><strong>Conclusions: </strong>A circuit-and-development framework may improve hypothesis generation, domain-specific phenotyping, target-engagement assessment, and mechanism-aligned outcomes. Clinical translation, however, requires caution. Biomarkers should be validated as predictors of treatment response, cascade models should be tested longitudinally, and interventions should combine mechanism-informed targets with behavioral support that promotes generalization to daily life.</p>","PeriodicalId":8918,"journal":{"name":"Biological Psychiatry","volume":" ","pages":""},"PeriodicalIF":10.3,"publicationDate":"2026-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149179310","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Erratum to: Triple Interactions Between the Environment, Brain, and Behavior in Children: An ABCD Study. 儿童环境、大脑和行为之间的三重相互作用:一项ABCD研究。
IF 10.3 1区 医学
Biological Psychiatry Pub Date : 2026-10-13 DOI: 10.1016/j.biopsych.2026.09.015
{"title":"Erratum to: Triple Interactions Between the Environment, Brain, and Behavior in Children: An ABCD Study.","authors":"","doi":"10.1016/j.biopsych.2026.09.015","DOIUrl":"https://doi.org/10.1016/j.biopsych.2026.09.015","url":null,"abstract":"","PeriodicalId":8918,"journal":{"name":"Biological Psychiatry","volume":" ","pages":""},"PeriodicalIF":10.3,"publicationDate":"2026-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149179291","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genetic architecture and risk of suicide attempt across neurodevelopmental and psychiatric conditions. 神经发育和精神疾病中自杀企图的遗传结构和风险。
IF 10.3 1区 医学
Biological Psychiatry Pub Date : 2026-10-13 DOI: 10.1016/j.biopsych.2026.09.028
Anna Starnawska, Trine Tollerup Nielsen, Jakob Grove, Juan Cordero-Solorzano, Jonas Bybjerg-Grauholm, Elizabeth C Corfield, Richard J L Anney, Anna R Docherty, Anders D Børglum, Ditte Demontis
{"title":"Genetic architecture and risk of suicide attempt across neurodevelopmental and psychiatric conditions.","authors":"Anna Starnawska, Trine Tollerup Nielsen, Jakob Grove, Juan Cordero-Solorzano, Jonas Bybjerg-Grauholm, Elizabeth C Corfield, Richard J L Anney, Anna R Docherty, Anders D Børglum, Ditte Demontis","doi":"10.1016/j.biopsych.2026.09.028","DOIUrl":"https://doi.org/10.1016/j.biopsych.2026.09.028","url":null,"abstract":"<p><strong>Background: </strong>Suicide attempt (SA) is prevalent among individuals with neurodevelopmental and psychiatric conditions, yet similarities and differences in the genetic architecture of SA across these conditions remain unclear.</p><p><strong>Methods: </strong>In the iPSYCH cohort (N=98,069), SA was identified using ICD-10 codes among individuals diagnosed with attention-deficit hyperactivity disorder (ADHD) (N=22,962), autism (N=17,670), schizophrenia (N=5,974), bipolar disorder (N=3,028), depression (N=28,844), and controls (N=34,049). We evaluated 21 polygenic scores (PGSs) in individuals with and without SA within each diagnosis, stratified individuals into PGS quantiles, estimated absolute SA risk, and conducted sex-stratified analyses.</p><p><strong>Results: </strong>SA was 1% among controls but ranged from 5% in autism to 31% in schizophrenia. Several PGSs were increased in individuals with SA across diagnoses, including PGS for ADHD, depression, and substance use disorders (SUD). SA-PGS stratification showed marked SA absolute risk differences, e.g., 40% in the top PGS tertile vs 29% in the lowest tertile in schizophrenia. PGS-loads did not differ between females and males with SA across diagnoses. However, absolute SA risk differed substantially. In the highest SA-PGS tertile in ADHD, the absolute SA risk reached 36% for females and 22% for males and was further increased to 48% in those with comorbid SUD.</p><p><strong>Conclusions: </strong>SA genetic architecture is similar across neurodevelopmental and psychiatric conditions and individuals can be stratified into SA risk groups based on PGSs, and co-occuring SUD. Being a female or having comorbid SUD are strong risk factors for SA, however SA common variants, still affect SA risk in the presence of those factors.</p>","PeriodicalId":8918,"journal":{"name":"Biological Psychiatry","volume":" ","pages":""},"PeriodicalIF":10.3,"publicationDate":"2026-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149179261","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of a messenger RNA therapy for schizophrenia. 一种信使RNA治疗精神分裂症的进展。
IF 10.3 1区 医学
Biological Psychiatry Pub Date : 2026-10-12 DOI: 10.1016/j.biopsych.2026.10.004
Nicole W Simons, Vibhuti Patel, Haoyuan Li, Shruti Iyer, Yichen Zhong, Dinglingge Cao, Changyue Yu, Deborah Obiajulu, Katherine Keller, Gavin Hynes, Simon Lee, Rajiv Nadukuru, Esther Cheng, Earnest P Chen, Alice Hashemi, Anina N Lund, Henry C Rogers, Rachel Jackson, Michael Preuss, Heather Thibeau, Girish N Nadkarni, Lora E Liharska, Dennis S Charney, Mafalda Barbosa, Samuele G Marro, René S Kahn, Nan Yang, Yizhou Dong, Alexander W Charney
{"title":"Development of a messenger RNA therapy for schizophrenia.","authors":"Nicole W Simons, Vibhuti Patel, Haoyuan Li, Shruti Iyer, Yichen Zhong, Dinglingge Cao, Changyue Yu, Deborah Obiajulu, Katherine Keller, Gavin Hynes, Simon Lee, Rajiv Nadukuru, Esther Cheng, Earnest P Chen, Alice Hashemi, Anina N Lund, Henry C Rogers, Rachel Jackson, Michael Preuss, Heather Thibeau, Girish N Nadkarni, Lora E Liharska, Dennis S Charney, Mafalda Barbosa, Samuele G Marro, René S Kahn, Nan Yang, Yizhou Dong, Alexander W Charney","doi":"10.1016/j.biopsych.2026.10.004","DOIUrl":"https://doi.org/10.1016/j.biopsych.2026.10.004","url":null,"abstract":"<p><strong>Background: </strong>Few gene-disease associations identified by human genetic studies lead to new drugs that advance to first-in-human trials. Schizophrenia exemplifies this translational gap: thousands of gene-disease associations have been reported, but antipsychotics act via mechanisms introduced in the 1950s. To close the gap, clinical research strategies are needed that generalize across genes and diseases.</p><p><strong>Methods: </strong>Candidate drug targets were defined as genes linked to schizophrenia by population-based studies. Clinical validation of candidate targets was performed through family-based studies. The molecular effects of clinically validated targets were confirmed by correcting mutations in the neurons from affected family members. For one validated target, a messenger RNA (mRNA) drug was developed, and pre-clinical studies of the drug were performed.</p><p><strong>Results: </strong>Carriers of rare protein-truncating variants (PTVs) in schizophrenia risk genes were identified in 30,813 patients of a US healthcare system. These included two female relatives with a rare PTV in GRIA3, which encodes the GluA3 subunit of the AMPA-type glutamate receptor. Further investigation of the family found an X-linked pattern of inheritance between the PTV and severe mental illness. Correction of the PTV in neurons of affected male family members restored GRIA3 expression. A GRIA3 mRNA drug was developed and in mice was well tolerated, resulted in broad brain expression of GluA3, and rescued behavioral abnormalities in a pharmacologically induced psychosis model (MK-801).</p><p><strong>Conclusions: </strong>Further development toward clinical evaluation of a novel GRIA3 mRNA drug to treat schizophrenia is warranted.</p>","PeriodicalId":8918,"journal":{"name":"Biological Psychiatry","volume":" ","pages":""},"PeriodicalIF":10.3,"publicationDate":"2026-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149163906","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Excitation-Inhibition Balance and Fronto-Limbic Connectivity Distinguish TMS Treatment Outcomes in Refractory Depression. 兴奋-抑制平衡和额边缘连通性区分经颅磁刺激治疗难治性抑郁症的疗效。
IF 10.3 1区 医学
Biological Psychiatry Pub Date : 2026-10-12 DOI: 10.1016/j.biopsych.2026.09.027
Davide Momi, Zheng Wang, Mohammad P Oveisi, Kevin Kadak, Sorenza P Bastiaens, Jennifer I Lissemore, Yoshihiro Noda, Jonathan Downar, Fidel Vila Rodriguez, Rebecca Strafella, Zafiris J Daskalakis, Christoph Zrenner, Reza Zomorrodi, Camarin E Rolle, Manish Saggar, Nolan Williams, Corey J Keller, Daniel M Blumberger, Daphne Voineskos, John D Griffiths
{"title":"Excitation-Inhibition Balance and Fronto-Limbic Connectivity Distinguish TMS Treatment Outcomes in Refractory Depression.","authors":"Davide Momi, Zheng Wang, Mohammad P Oveisi, Kevin Kadak, Sorenza P Bastiaens, Jennifer I Lissemore, Yoshihiro Noda, Jonathan Downar, Fidel Vila Rodriguez, Rebecca Strafella, Zafiris J Daskalakis, Christoph Zrenner, Reza Zomorrodi, Camarin E Rolle, Manish Saggar, Nolan Williams, Corey J Keller, Daniel M Blumberger, Daphne Voineskos, John D Griffiths","doi":"10.1016/j.biopsych.2026.09.027","DOIUrl":"https://doi.org/10.1016/j.biopsych.2026.09.027","url":null,"abstract":"<p><strong>Background: </strong>Intermittent theta burst stimulation (iTBS) targeting the left dorsolateral prefrontal cortex (DLPFC) is effective for treatment-resistant depression, but outcomes remain variable. The neurophysiological mechanisms underlying response remain poorly understood, limiting precision neuromodulation.</p><p><strong>Methods: </strong>We combined transcranial magnetic stimulation with electroencephalography (TMS-EEG) and connectome-based Jansen-Rit neural mass modeling to investigate the mechanistic basis of treatment efficacy in 90 patients with treatment-resistant depression. Individualized whole-brain models were fitted to pre- and post-iTBS TMS-evoked potentials, yielding subject-specific estimates of synaptic connectivity, excitation-inhibition (E/I) balance, and cortical dynamics. Brain states were defined by singular value decomposition of the model's population activity, and partial least squares analysis with nested cross-validation identified the brain-state pattern distinguishing responders from non-responders.</p><p><strong>Results: </strong>We identified two neurophysiological signatures associated with treatment response. First, responders showed greater post-treatment reductions in 3-10 Hz oscillatory power, driven by shifts in E/I balance toward greater inhibitory control through reduced excitatory drive and increased inhibitory-to-pyramidal connectivity. Second, a pre-treatment brain state characterized by opposite-polarity dynamics between subgenual anterior cingulate cortex (sgACC) and left DLPFC distinguished responders from non-responders, consistent with prior fMRI findings on frontolimbic anticorrelation. Neural trajectory analysis further revealed greater dynamical reorganization and increased attractor stability in responders following treatment.</p><p><strong>Conclusions: </strong>These findings provide a neurophysiologically-informed framework linking iTBS treatment efficacy to specific changes in cortical E/I balance and frontolimbic circuit dynamics, pointing toward candidate markers that, with subject-specific structural connectivity and independent validation, may inform personalized neuromodulation approaches in treatment-resistant depression.</p>","PeriodicalId":8918,"journal":{"name":"Biological Psychiatry","volume":" ","pages":""},"PeriodicalIF":10.3,"publicationDate":"2026-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149164111","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The genetic orchestra of autism and its intersections with epilepsy, intellectual disability, and ADHD. 自闭症的基因管弦乐队及其与癫痫、智力残疾和多动症的交叉。
IF 10.3 1区 医学
Biological Psychiatry Pub Date : 2026-10-09 DOI: 10.1016/j.biopsych.2026.10.003
Sélin Korkmaz, Jean-Madeleine De Sainte Agathe, Freddy Cliquet, L Caitlin Martin, Eli Barthome, Mathis Fleury, Julie Segers, Stéf Bonnot-Briey, Vincent Grimaldi de Puget, Yanlin Zhou, Dieter Wolke, Jakob Grove, Anders D Børglum, Richard Delorme, Claire S Leblond, Thomas Bourgeron
{"title":"The genetic orchestra of autism and its intersections with epilepsy, intellectual disability, and ADHD.","authors":"Sélin Korkmaz, Jean-Madeleine De Sainte Agathe, Freddy Cliquet, L Caitlin Martin, Eli Barthome, Mathis Fleury, Julie Segers, Stéf Bonnot-Briey, Vincent Grimaldi de Puget, Yanlin Zhou, Dieter Wolke, Jakob Grove, Anders D Børglum, Richard Delorme, Claire S Leblond, Thomas Bourgeron","doi":"10.1016/j.biopsych.2026.10.003","DOIUrl":"https://doi.org/10.1016/j.biopsych.2026.10.003","url":null,"abstract":"<p><p>Autism is a complex condition with marked phenotypic variability and a multifactorial etiology orchestrated by diverse genetic and environmental influences. In this review, we dissect what we refer to as autism's \"genetic orchestra\", spanning from the high-impact \"soloists\", de novo and ultra-rare variants with large effect sizes, to the \"polyphonic background\" of common variants which individually exert modest effects but collectively have significant impact. We examine how this orchestra wires neural circuits, with convergent biological pathways modulating synaptic function and chromatin remodeling. Although de novo, rare, and common variants are often studied independently, converging evidence supports a model whereby their influences are largely additive. This genetic orchestra is not condition-specific; autism frequently co-occurs with other neurodevelopmental and psychiatric conditions, reflecting substantial pleiotropy across both rare and common variant landscapes. Notably, ultra-rare variants tend to associate with co-occurring intellectual disability, ADHD, epilepsy, and psychiatric conditions highlighting their high phenotypic impact. Beyond genetics, layers of environmental and contextual factors further modulate clinical outcomes. In this framework, we also discuss the challenges of identifying genetic variants associated with autism through clinical genetic testing, where yields remain context-dependent, varying by sex and co-occurring conditions. Finally, we address current limitations and future directions in refining our understanding of autism's genetic basis.</p>","PeriodicalId":8918,"journal":{"name":"Biological Psychiatry","volume":" ","pages":""},"PeriodicalIF":10.3,"publicationDate":"2026-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149147335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Connection-Level Multi-Omics Reveals Cerebellar-Cortical Dysconnectivity and Divergent Molecular Signatures Across Major Psychiatric Disorders 连接水平的多组学揭示了主要精神疾病的小脑-皮质连接障碍和不同的分子特征
IF 10.6 1区 医学
Biological Psychiatry Pub Date : 2026-10-01 DOI: 10.1016/j.biopsych.2026.09.020
Yunheng Diao,Yuanyuan Huang,Baoyuan Zhu,Minxin Guo,Wei Wang,Zhaobo Li,Xin Zhang,Kai Li,Wenhao Li,Hongyu Wang,Jing Zhou,Xiaobo Li,Fengchun Wu,Kai Wu
{"title":"Connection-Level Multi-Omics Reveals Cerebellar-Cortical Dysconnectivity and Divergent Molecular Signatures Across Major Psychiatric Disorders","authors":"Yunheng Diao,Yuanyuan Huang,Baoyuan Zhu,Minxin Guo,Wei Wang,Zhaobo Li,Xin Zhang,Kai Li,Wenhao Li,Hongyu Wang,Jing Zhou,Xiaobo Li,Fengchun Wu,Kai Wu","doi":"10.1016/j.biopsych.2026.09.020","DOIUrl":"https://doi.org/10.1016/j.biopsych.2026.09.020","url":null,"abstract":"","PeriodicalId":8918,"journal":{"name":"Biological Psychiatry","volume":"22 1","pages":""},"PeriodicalIF":10.6,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149088958","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sleep and Drug Use: Neuroimaging Evidence for a Multidimensional Brain Framework 睡眠和药物使用:多维大脑框架的神经影像学证据
IF 10.6 1区 医学
Biological Psychiatry Pub Date : 2026-10-01 DOI: 10.1016/j.biopsych.2026.09.024
Rui Zhang,Nora D. Volkow
{"title":"Sleep and Drug Use: Neuroimaging Evidence for a Multidimensional Brain Framework","authors":"Rui Zhang,Nora D. Volkow","doi":"10.1016/j.biopsych.2026.09.024","DOIUrl":"https://doi.org/10.1016/j.biopsych.2026.09.024","url":null,"abstract":"","PeriodicalId":8918,"journal":{"name":"Biological Psychiatry","volume":"36 1","pages":""},"PeriodicalIF":10.6,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149088959","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TMS-Evoked Cortical Reactivity Signatures as a Multidimensional Biomarker of Depression: A TMS-EEG Meta-Analysis from Diagnosis to Prognosis 颅磁刺激诱发的皮层反应特征作为抑郁症的多维生物标志物:从诊断到预后的颅磁刺激-脑电图荟萃分析
IF 10.6 1区 医学
Biological Psychiatry Pub Date : 2026-10-01 DOI: 10.1016/j.biopsych.2026.09.022
Ji-Yu Xie,Tao Zhao,Liang Guo,Dong Li,Yanjie Zhao,Zhimin Wang,Pengfei Wang,Linghui Meng,Gang Wang,Zhi Yang
{"title":"TMS-Evoked Cortical Reactivity Signatures as a Multidimensional Biomarker of Depression: A TMS-EEG Meta-Analysis from Diagnosis to Prognosis","authors":"Ji-Yu Xie,Tao Zhao,Liang Guo,Dong Li,Yanjie Zhao,Zhimin Wang,Pengfei Wang,Linghui Meng,Gang Wang,Zhi Yang","doi":"10.1016/j.biopsych.2026.09.022","DOIUrl":"https://doi.org/10.1016/j.biopsych.2026.09.022","url":null,"abstract":"","PeriodicalId":8918,"journal":{"name":"Biological Psychiatry","volume":"48 1","pages":""},"PeriodicalIF":10.6,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149088961","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书